财经首页
|
新浪首页
|
新浪导航
财经首页
美股首页
滚动
评论
经济数据
美股列表
中国概念股
美股行情中心
美股自选
(NVRO)
公司资讯
finviz | 2022年09月02日 23:31
Why Is Nevro (NVRO) Down 1% Since Last Earnings Report?
finviz | 2022年09月02日 21:18
Nevro's (NVRO) PDN Therapy Gets Positive Coverage Updates
finviz | 2022年09月01日 23:19
Nevro Wins Multiple Coverage Options For Spinal Cord Stimulation In Diabetic Neuropathy
finviz | 2022年09月01日 19:00
Nevro Announces Multiple Positive Coverage Updates for the Treatment of Painful Diabetic Neuropathy
finviz | 2022年08月30日 20:32
Here's Why You Should Hold on to Nevro (NVRO) Stock for Now
finviz | 2022年08月09日 19:00
Nevro Announces Participation In Upcoming Investor Conferences
finviz | 2022年08月06日 00:58
Nevro (NVRO) Q2 Earnings Beat Estimates, FY22 View Revised
finviz | 2022年08月04日 07:25
Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates
finviz | 2022年08月04日 04:05
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
finviz | 2022年08月01日 19:00
Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations
finviz | 2022年07月21日 19:00
Nevro to Present at the Canaccord Genuity 42nd Annual Growth Conference
finviz | 2022年07月06日 19:00
Nevro to Report Second Quarter 2022 Financial Results
finviz | 2022年07月05日 19:00
Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation Therapy
finviz | 2022年07月05日 18:49
Is Nevro (NYSE:NVRO) Using Too Much Debt?
finviz | 2022年06月24日 00:16
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio
finviz | 2022年06月08日 04:05
Clinical Data Presented at American Diabetes Association 82nd Scientific Sessions Reinforce Significant and Durable Benefits of Nevro's HFX 10 kHz Therapy
首页  上页
下页